Bristol Myers Squibb (BMY) Retained Earnings (2009 - 2026)

Bristol Myers Squibb has disclosed Retained Earnings across 18 years of filings, most recently posting -$1.4 billion for Q1 2026.

• In Q1 2026, Retained Earnings fell 108.51% year-over-year to -$1.4 billion; the TTM figure through Mar 2026 stood at -$1.4 billion (down 108.51% YoY), while the FY2025 annual figure was -$1.5 billion, down 23.1% from the prior year.
• Retained Earnings advanced to -$1.4 billion in Q1 2026, from -$1.5 billion in the prior quarter.
• Over the last five years, Retained Earnings for BMY reached as high as $25.5 billion in Q4 2022 and fell as low as -$1.6 billion in Q2 2025.
• The 5-year median for Retained Earnings is -$1.2 billion (2024), against an average of $7.4 billion.
• Annual changes were most pronounced in 2024 — Retained Earnings surged 1351.71% — and 2026, when it slumped 108.51%.
• A 5-year view of Retained Earnings shows it stood at $25.5 billion in 2022, then slumped by 106.06% to -$1.5 billion in 2023, then increased by 19.92% to -$1.2 billion in 2024, then dropped by 23.1% to -$1.5 billion in 2025, then climbed by 10.1% to -$1.4 billion in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered -$1.4 billion, -$1.5 billion, and $17.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.